Sarojini et al. [17] reported that a dose rate of 2400 MU/min enhances apoptosis in WC00046, WC00060, and WC00081 melanoma cells through a Fas-mediated apoptotic pathway, suggesting a potential antimelanoma therapy by using a combination of high dose-rate (2400 MU/min) and low total dose (0.5 Gy). This evidence concerns the gene FAS and melanoma.